Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Healthcare Biotechnology
Hemostemix Inc. is a Canada-based autologous stem cell therapy company. The Company has developed, patented, and is scaling a patient’s blood-based stem cell therapeutics platform, which includes angiogenic cell precursors, neuronal cell precursors and cardiomyocyte cell precursors. The Company holds 87 patents on the derivation of three stem cell lineages from the patient’s blood, including... see more

TSXV:HEM - Post Discussion

Hemostemix Inc > Highly undervalued!!!
View:
Post by Eprint on Dec 06, 2020 11:20pm

Highly undervalued!!!

This stock is highly undervalued!!!
https://youtu.be/CyGwyibdoR0
Comment by milstogo on Dec 07, 2020 6:24am
This Company Is Amazing!!!  Here are some ACP Testomonials  Regenocyte Adult Stem Cell Therapy https://hemostemix.com/acp-testimonials/
Comment by bullbear007 on Dec 07, 2020 1:11pm
This is going to blast off!
Comment by LFC1973 on Dec 07, 2020 2:57pm
For the 20/1 share consolidation, do they have to provide any advanced notice?  Or can they do this anytime before December 31 since it has been approved?
Comment by Eprint on Dec 08, 2020 1:10am
There is NO talk of share consolidation. Did you just make that up #LFC1973?
Comment by 22Ontarioboy222 on Dec 08, 2020 1:29am
The share consolidation will take place before the end of the year 20:1 Cheers!!
Comment by LFC1973 on Dec 08, 2020 7:26am
Hi Eprint, See below: CONSOLIDATION UPDATE Further to the approval of the 20 for 1 Common Share consolidation (the “Consolidation”) that was approved at the annual general and special meeting of shareholders of Hemostemix held on May 6, 2020‎, Hemostemix ‎intends to implement the Consolidation prior to December 31, 2020. Hemostemix will provide further information in ‎respect of the ...more  
Hemostemix Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities